In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption.
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | ISSN: 1522-8002 |
| Author | Larbouret, Christel, Gaborit, Nadège, Chardès, Thierry, Coelho, Mickaël, Campigna, Emmanuelle, Bascoul-Mollevi, Caroline, Mach, Jean-Pierre, Azria, David, Robert, Bruno, Pèlegrin, André |
| Maintainer | CCSD |
| Last Updated | May 23, 2026, 16:28 (UTC) |
| Created | May 23, 2026, 16:28 (UTC) |
| Identifier | inserm-00682017 |
| Language | en |
| Rights | https://about.hal.science/hal-authorisation-v1/ |
| contributor | Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1) ; Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM) |
| creator | Larbouret, Christel |
| date | 2012-02-23T00:00:00 |
| harvest_object_id | 79831a1a-dde9-4fab-9115-6653d9ae8206 |
| harvest_source_id | 3374d638-d20b-4672-ba96-a23232d55657 |
| harvest_source_title | test moissonnage SELUNE |
| metadata_modified | 2026-04-21T00:00:00 |
| relation | info:eu-repo/semantics/altIdentifier/doi/10.1593/neo.111602 |
| set_spec | type:ART |